Inventor · disambiguated record
Dan-Ning Hu
Also filed as: HU DAN · HU DAN-NING
5 granted patents·7 pending applications·4 citations·filing 2003–2019
65Inventor score
Files withTHE NEW YORK EYE AND EAR INFIRMARY4UNIV JINAN2HU DAN-NING1NEW YORK EYE & EAR IN RY FA1NEW YORK EYE AND EAR IN RY F1
Top patents by PatentIndex Score
12 records- 0164US6943024B2Epidermal melanocyte culture formulationsFiled 2003·Granted Sep 13, 2005·4 cites·17 claims
- 0259US2020000740A1Zeaxanthin for tumor treatmentTHE NEW YORK EYE AND EAR INFIRMARY·Filed 2019·Application pending·0 cites
- 0356US2018318235A1Zeaxanthin for Tumor TreatmentTHE NEW YORK EYE AND EAR INFIRMARY·Filed 2018·Application pending·0 cites
- 0455US2018036257A1Zeaxanthin for tumor treatmentTHE NEW YORK EYE AND EAR INFIRMARY·Filed 2017·Application pending·0 cites
- 0553US2013302319A1Zeaxanthin for tumor treatmentNEW YORK EYE AND EAR IN RY FA·Filed 2013·Application pending·0 cites
- 0652US2017014354A1Zeaxanthin for tumor treatmentTHE NEW YORK EYE AND EAR INFIRMARY·Filed 2016·Application pending·0 cites
- 0748US2015209303A1Zeaxanthin for tumor treatmentNEW YORK EYE AND EAR IN RY F·Filed 2015·Application pending·0 cites
- 0844US10673009B2Planar electroluminescent devices and uses thereofUNIV PEKING SHENZHEN GRADUATE SCHOOL·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 0944US2007178074A1Chondrocyte Culture FormulationsHU DAN-NING·Filed 2006·Application pending·0 cites
- 1041US7132279B2Epidermal melanocyte culture formulationsNEW YORK EYE & EAR IN RY FA·Filed 2005·Granted Nov 7, 2006·0 cites·1 claims
- 1137US10457702B2Dicaffeoyl spermidine cyclized derivatives and use thereofUNIV JINAN·Filed 2017·Granted Oct 29, 2019·0 cites·9 claims
- 1234US11208427B2Dicaffeoyl spermidine derivative glycosides and use thereofUNIV JINAN·Filed 2017·Granted Dec 28, 2021·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Dan-Ning Hu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →